In clinical settings, the expression, nuclear accumulation, and dephosphorylation at Ser256 of FoxO1 were reported in patients with NASH, consistent with the reduction of Akt activation [41]. Here, FOXO1 is linked to metabolic dysfunction-associated steatohepatitis.